Instituto de Investigaciones Biomédicas Alberto Sols-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  2. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV

  3. Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

    OncoImmunology, Vol. 7, Núm. 1